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Abstract 
Introduction: In order to facilitate our understanding of health-related quality of life (HRQoL) 
for IBD patients, it is critical to explore their subjective experiences with the disease. Research 
has suggested that current modes of assessing HRQoL (i.e., generic and disease-specific 
measures) may not fully represent all dimensions of patients' HRQoL. The purpose of this study 
was to examine IBD patients' subjective experiences of the daily impact of IBD, and categorize 
dimensions of their HRQoL affected by IBD, as identified by the patients themselves.  
Methods: 282 patients with IBD provided answers to the qualitative question "How has IBD 
affected your daily activities?" A content analysis using NVivo 2.0 was conducted on the 
participants’ responses to this question to reveal dimensions of their HRQoL.  
Results: The analysis yielded six dimensions and several sub-dimensions of HRQoL, including 
physical (systemic functioning, daily functioning, energy/vitality, pain), emotional, social, 
cognitive (functioning, attending to disease), self-regulation (taking control, loss of control, and 
neutral), and practical functioning. Discussion: These results reflect previous findings, but also 
reveal several dimensions of HRQoL not included in current measures of HRQoL for IBD 
patients (i.e., cognitive, self-regulation, and practical). The implications of these findings for 
future measurement of HRQoL and research with IBD patients are discussed.  
Key Words: Inflammatory bowel diseases, Quality of life, Measurement, Qualitative research 
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Introduction 
Inflammatory Bowel Disease (IBD) is comprised of three distinct but related medical 
conditions: Crohn’s disease (CD), ulcerative colitis (UC), and indeterminate colitis. A complex 
disorder of uncertain pathogenesis and etiology, IBD is characterized by chronic inflammation of 
the gastrointestinal tract in a pattern of alternating periods of remission and relapse. With no 
known cure, treatment is often typified by attempts to control inflammation through palliative 
medication, diet, physical activity, and as a last resort, surgery [1,2].  
The impact of IBD is felt physically, socially, and emotionally. Physical concerns may 
include, but are not limited to, abdominal cramps, rectal bleeding, systemic inflammation, 
diarrhea, nausea, weight loss, constipation, and fatigue. In addition to these physical concerns, 
IBD patients also contend with the fact that the disease is not well understood. IBD patients are 
faced with daily stigma, fear, and revulsion, and often describe feelings of embarrassment and 
helplessness [1,3]. Research has indicated that IBD patients may also experience decreased 
sexual functioning [4], an impact on their resources due to the expense of medication and visits 
to the doctor [5], and other costs including refusal of insurance and mortgage [6].  
While more emphasis is generally placed on treatment and management of the physical 
symptoms of IBD, researchers have also acknowledged the need to examine the subjective 
aspects of IBD patients’ health (i.e., health-related quality of life or HRQoL). In many cases, this 
research has indicated that there can be considerable impairment in HRQoL [7-11]. However, 
where it was once imperative to determine if HRQoL was impaired as a result of IBD, it is now 
critical to clarify which dimensions of HRQoL are most impacted, and to what extent this impact 
is felt [12]. In order to determine these effects, many researchers have focused on the 
measurement of HRQoL [1,13].  
Living with IBD      4 
HRQoL is a multi-dimensional construct comprised of physical, social, and psychological 
functioning, overall satisfaction and well-being, and perceptions of health status, and also 
includes neuropsychological functioning, personal productivity, intimacy and sexual functioning, 
sleep disturbance, pain, symptoms, and spirituality [14]. This multi-dimensionality is reflected in 
the two modes used to measure the construct: generic and disease-specific questionnaires. 
Generic measures do not offer direct insight into specific conditions, but are able to perform and 
summarize across conditions [10,15].  Such scales are generally more likely to meet critical 
standards of reliability and validity [10], but critics often rebuff the value of such measures based 
on their lack of specificity. Of the many generic HRQoL scales that exist, the Medical Outcomes 
Study Short-Form 36 (SF-36) [16] is the mostly commonly used measure [17]. 
Disease-specific measures, meanwhile, generate detailed information related to the 
disease in question [13]. For IBD in particular, psychosocial concerns are at least as important as 
physical ones [18]; such factors directly affect the development of the disease, and the patient’s 
perception of their HRQoL [19]. While researchers have argued that some IBD-specific 
measures only examine the physical impact of the disease [10], more recent scales generally 
acknowledge the importance of psychosocial concerns, and are seen as more effective than 
generic ones based on the fact that they have been  designed specifically for the disease under 
study [10]. There are multiple IBD-specific scales available, however the Inflammatory Bowel 
Disease Questionnaire (IBDQ) [9] is the most commonly used instrument [19].  
Researchers have compared generic and disease-specific measures in an attempt to 
determine which provides the most complete assessment of HRQoL. For IBD in particular, 
McColl and colleagues [20] compared the SF-36 and IBDQ and found that the IBDQ was better 
at discriminating between sub-groups categorized by disease-specific variables, whereas the SF-
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36 was better at discriminating between sub-groups defined by co-morbidity [20]. They 
concluded that disease-specific and generic measures are complementary, a finding that has been 
supported by previous research [9]. The fact that disease-specific and generic measures together 
offer a more complete picture of HRQoL  than either on their own suggests that there may be 
aspects of HRQoL that are not captured by these measures. We have also recognized the need to 
include patients’ subjective experiences in the process of evaluating HRQoL, and as a result it is 
then important to critically examine the development of HRQoL measures to determine if and 
where our understanding of the IBD patients’ HRQoL can become more complete. Because the 
SF-36 and the IBDQ are the most commonly used instruments of their respective type (i.e., 
generic and disease-specific) to assess HRQoL for IBD patients, and because previous work has 
compared these two measures with regard to their ability to assess HRQoL, the remainder of this 
paper will focus on and related new findings to these measures in particular.  
Development of the SF-36 and IBDQ. The rationale behind the SF-36 was that the 
patient’s point of view is central to the study of medical care outcomes. Ware and Sherbourne 
[16] argued that the deficiency in patient input was due to lack of valid and easy methods to 
collect data related to patient experiences. After reviewing many established instruments [16], 
items were adapted for their place in the SF-36. The result was a measure that included eight 
subscales: physical functioning, role physical, bodily pain, general health perceptions, vitality, 
social functioning, role emotional, and mental health.  
 The IBDQ, meanwhile, was created out of the need to include details about the IBD 
patient’s subjective emotional and social functioning [9]. An open-ended questionnaire based on 
IBD-specific problems was sent to both clinicians and IBD patients. The resultant list of 
problems generated was then sent to another set of IBD patients, who were asked to identify 
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which of these physical, emotional, and social problems they had experienced. The most 
common and critical problems were included in the IBDQ. The final measure included four 
subscales: bowel symptoms, systemic symptoms, emotional, and social.  
Similarities in the construction of the two questionnaires are evident. The rationale 
behind each was that there was a need to generate a detailed picture of patients’ subjective 
functioning. Both sets of authors were operating under the assumption that the development of a 
psychometrically sound instrument would allow for patients’ experiences to be illuminated. Both 
measures were also grounded in the literature; while the SF-36 was developed directly from the 
literature, the IBDQ was a combination of patient and practitioner input, and supportive research. 
The main difference between the two questionnaires was that the IBDQ allowed for patient input 
from the very generation of items, while the SF-36 relied on items that had been generated 
previously (assuming that these items were inclusive of patients’ experiences). Thus, while both 
scales claim to lobby for the inclusion of patients’ subjective experiences, only the IBDQ 
allowed for this inclusion at the level of generating items. However, the authors of the IBDQ 
framed the open-ended questions from the position that any issues resulting from living with IBD 
were inherently ‘problems.’ In other words, the IBD patients were not able to define for 
themselves how they experienced the disease. If there had been positive changes in their lives as 
a result of the IBD, such as a healthier diet, there was no room to describe them in the context of 
the IBDQ.    
The question remains if such measures fully represent patients’ experiences. A step 
towards filling this void is to use qualitative methods to ask the patients themselves how IBD has 
affected their lives. In the process, the patients can both define their experiences with the disease 
for themselves (i.e., relate which dimensions of their HRQoL have been most affected by the 
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disease), and explore these experiences without being primed to see them as ‘problems.’ The aim 
of this research was to explore how the patient’s voice is included in the process of measuring 
HRQoL. Specifically, the first purpose of this study was to explore IBD patients' subjective 
experiences of the daily impact of IBD by categorizing dimensions of their HRQoL that had 
been affected by the disease, as identified by the patients themselves. The second purpose was to 
compare these experiences with the dimensions utilized in current HRQoL measures (i.e., the 
SF-36 and IBDQ)  in the hope that this work could help to determine if such measures represent 
IBD patients’ experiences and truly ‘give voice’ to this population. 
Methods 
The current study involved a secondary analysis of data collected from a larger study 
examining the well-being of people with living with IBD. Institutional research ethics clearance 
was received both for the initial data collection and for this secondary analysis. Participants were 
recruited over a five month period spanning 2002 to 2003 via notices posted in on-line support 
groups, and in the community at gastroenterologist’s offices in eastern Ontario. The majority of 
the participants completed the survey on-line, although they were given the option to complete a 
paper version of the survey by mail. Participants completing the survey on-line read a web page 
with the letter of information and conveyed their consent to participate by clicking a button 
which linked to the survey. Surveys were submitted electronically to a secure server and were 
anonymous as they did not contain any personally identifying information. Electronic data was 
stored in a secure manner to further maintain confidentiality.  
A sample of 291 adults diagnosed with IBD (i.e., CD, UC, or ‘other IBD’) was recruited 
in the original study. However, only 282 were included in this analysis due to missing data 
related to the qualitative question being examined.  Of the final 282 participants included in the 
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current analysis, 246 individuals participated on-line, and 36 completed paper versions of the 
survey which were returned by mail. Of the nine participants excluded, eight had completed the 
survey online.  
Participants completed a survey that included demographics questions and questions 
about their HRQoL, coping, health perceptions, and other aspects of their disease. Following the 
completion of the IBDQ, multiple questions related to coping, and a single rating scale of how 
IBD had affected their lives, participants were asked the open-ended question, “How has IBD 
affected your daily activities?” The question was phrased in this neutral manner to avoid priming 
positive or negative responses. Because of the unpredictable nature of IBD, the focus of this 
question was the impact of disease on the daily, lived experiences of people, rather than on the 
overall impact of IBD. Responses to this open-ended question comprise the data of the current 
study. 
Responses ranged in length from half a page to only a few words, with most participants 
offering three to four sentences. The transcripts were read multiple times by the researchers, and 
the textual data (i.e., participants’ responses to the qualitative question) were explored 
inductively through a content analysis [21]. Using Nvivo 2.0, meaning units (i.e., responses) 
were inductively tagged for common themes and placed into more general conceptual categories 
reflecting dimensions of their HRQoL This process was ongoing and required multiple open 
codings before the final categories were achieved. Two researchers reviewed the coding; when 
the researchers disagreed about where to place a response, a discussion took place until a 
consensus was reached.  
Although purists will argue that traditional content analysis is quantitative in nature and 
scope, there are variants to this type of analysis [22]. The type of textual analysis and open 
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coding used in this study allowed for the researchers to identify themes inductively as they 
emerged from the data, and was thus deemed most appropriate to meet the research goals.  
Results 
Demographic and disease-specific characteristics of the original and final samples are 
presented in Table 1. The final sample was largely Caucasian, female, living in North America, 
and diagnosed with CD. In comparison, the discarded sample had a shorter time since diagnosis, 
was more likely to be single, and more likely to be diagnosed with UC. 
The analysis revealed six broad dimensions of HRQoL, and several sub-dimensions. 
These dimensions included: physical (systemic functioning, daily functioning, energy/vitality, 
and pain), emotional, social, cognitive (functioning and attending to disease), a self-regulatory 
dimension (taking control, loss of control, and neutral), and a practical dimension. 
Physical 
Participants identified aspects of their physical lives that had been affected by the disease, 
including systemic functioning, daily functioning, energy/vitality, and pain. 
Physical systemic functioning. This sub-dimension was related to the literal physical 
functioning of the participants’ bodies. A well documented concern of IBD patients, systemic 
functioning was characterized by responses related to bowel and other bodily function. “Due to 
uncontrollable bowel movements sometimes I cannot even walk across the floor without having 
an accident. I cannot lift anything heavy due to the same as listed above.” (P 1537, female, CD) 
Physical daily functioning. These aspects were varied in nature, but dealt with the ability, 
or inability, to physically participate in daily tasks. The majority of participants identified their 
career or occupation, including student life, as having been affected, and noted that travel was 
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extremely difficult. Other issues included the inability to participate in physical activity, and in 
general, difficulty completing daily tasks such as housework, gardening, and other errands.  
I can no longer go to work or school because I’m usually in constant pain/nausea. I 
cannot trust myself to travel in the car because I get car sick and cannot control my 
bowels. When I go anywhere, my number one priority is to know where the toilets are. 
All I do is sit at home and sleep, eat, and watch TV now. (P 1678, female, CD) 
While the majority of responses were negative, there did appear to be instances where the 
effects of the disease were neutral or even positive. “It has also been positive. I definitely eat 
healthier, no chemical additives, avoid wheat for the most part, no white sugar.” (P 1629, male, 
UC) 
Physical energy/vitality. Similar to previous findings, many of the participants were 
concerned with their energy and/or vitality. Many participants complained of fatigue and the 
inability to carry out normal tasks due to lack of energy. For some, there was an increased need 
for sleep. Out of the entire category of responses related to this dimension, not one participant 
suggested a positive change in their energy as a result of the disease. “I have no energy to get 
things done. Getting up and making it through the day at work takes all I’ve got.” (P 1623, 
female, UC)
Physical pain. The pain experienced by participants ranged from cramping and joint pain 
to pain during sex and physical activity. While this category contained fewer responses than the 
other physical categories, it was evident that pain often played a large role in the experience of 
IBD. “Hurts to have sex sometimes, some days I am in a lot of pain and cannot function at all.” 
(P 1670, female, UC)
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Emotional 
The second category included all responses related to emotional dimensions, ranging 
from anxiety and depression to fear and loss of passion. An analysis of these responses suggests 
an intense emotional component resultant of specific physical aspects of the disease, and 
perceived social repercussions. 
I have anxiety whenever I need to go out of the house for fear of losing bowel control. I 
don’t want to go out with my spouse because I am embarrassed to have to stop on the 
side of the road to ‘go’ so I avoid going out with him. I also feel guilt because I have two 
small boys and I don’t always take them all the places I would like to because I am afraid 
of having to use the bathroom urgently. (P 1611, female, UC) 
Social 
Many of the participants felt that their social lives had been affected by IBD. In some 
instances, the participants felt that other people in their lives, including medical professionals, 
did not understand or value their experiences. Often, the participants noted that they could not 
participate in their social lives the way they once had. Several participants stated that the real 
change occurred not in how they participated in life, but rather in how they chose their friends.  
Before going anywhere I worry about whether or not I’m going to have an attack of 
diarrhea and ruin everybody’s plans. I immediately look for a bathroom wherever I am. I 
don’t socialize much anymore because I seem to always be sick and people get tired of 
inviting me to be with them. (P 1720, female, CD) 
Cognitive 
The fourth dimension was cognitive in nature, and included two sub-dimensions: 
functioning and attending to disease. 
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Cognitive functioning. This sub-dimension was characterized by responses dealing with a 
perceived reduction in cognitive functioning. Although some of the participants noted that the 
disease itself required a large portion of mental resources, others stated that the required 
medication to combat the disease had consequences for their cognitive ability. In many cases, the 
participants believed that IBD had a negative impact on their motivation, alertness, disposition, 
and general self image. “I find working more difficult particularly when IBD is active as this 
takes up a large proportion of mental resources. I feel fatigued and mentally slow compared to 
my ‘normal’ self” (P 1657, male, CD)
Cognitive attending to disease. For many of the participants, a significant amount of time 
was spent thinking or worrying about, and planning around IBD. Although not always perceived 
as a negative consequence of the disease, for many of the participants, the amount of time spent 
attending to the disease, and not spent freely on the rest of their daily lives, was a problem. “I 
spend an inordinate amount of time thinking about how to prevent getting a flare, what to do if I 
have a flare, and wondering if the blood I saw in my stool means I’m starting a major flare” (P 
1593, female, UC)
For other participants, living with IBD meant that they had to manage their disease and 
time through routines and improved organizational skills.  
Have to be much more organized in terms of eating (what I eat, when I eat, where). I 
need to know where toilet facilities are at all times. Basically, living with IBD is all about 
management, creating routines and diets etc. that suit your own needs. (P 1591, female, 
UC) 
Self-Regulation 
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A fifth dimension was also identified that dealt with self-regulation and control. Although 
initially perceived by the researchers to be cognitive in nature, it was soon recognized that these 
concerns were copious and distinct. Within this self-regulation dimension, there were three sub-
dimensions: taking control, loss of control, and neutral. 
Self-regulation taking control. The ways in which the three sub-dimensions were 
differentiated were subtle in nature. In most cases, it came down to the type of language used by 
the participant. In order to be characterized as ‘taking control’ the participants demonstrated that 
in the face of changes to their life as a result of IBD, they had taken control of disease-related 
issues. This meant that the participants used language such as, “I do,” “I am,” and “I plan,” and 
avoided using “I can’t,” and “I don’t.” In general there were fewer responses of this nature than 
the other two dimensions of self-regulation. “I feel that I have all control over IBD now. Most of 
the time I can effectively deal with any or all symptoms which I may have today” (P 1719, male, 
unknown). 
I also feel like I keep control of whatever health issues I do have some control over: e.g., 
low cholesterol diet, regular cardiovascular exercise, moderate or no use of alcohol, 
regular sleep patterns, avoidance of pesticide or hormone loaded food the best I can. (P 
1544, female, CD) 
Self-regulation loss of control. In stark contrast to the ‘taking control’ group, the 
participants categorized as ‘loss of control’ did use negatively toned language. Responses which 
fell into this sub-dimension were classified by the perception that as a result of living with IBD, 
control had been lost in many aspects of their lives. Often, these responses offered the most 
compelling evidence of changes to HRQoL. “I never leave the house – have not been out in 
years. Example – My truck is 17 years old and has less than 25000 miles (most of those were in 
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first five years). I’m a hermit.” (P 1564, male, CD) “I do not participate in life.” (P 1673, male, 
CD) “I can’t work anymore, what office wants a gray haired little old lady that farts 
uncontrollably?” (P 1740, female, other IBD) 
Self-regulation neutral. Although there were clear examples of taking control and losing 
control, there was also another sub-dimension of responses. For the neutral category, it was 
evident that some changes had been made in response to the disease, however, they were neither 
proactive, nor did they appear to be a result of relinquishing control. In contrast to the themes of 
controlling and managing the disease reflected in the ‘taking control’ group, these responses 
reflected themes of making changes as a result of being imposed upon by the disease. The 
responses in this sub-dimension were characterized by statements such as, “I have to,” or “I need 
to.” “I felt I had to leave an extremely high-pressure job (although I enjoyed it) to work in a less 
stressful environment.” (P 1561, female, CD) “I feel that every trip out of the house has to be 
planned around the bathroom” (P 1572, male, UC)
Practical 
The sixth and final dimension was more practical in nature. These responses were related 
to daily functioning that could not be categorized under any of the other five. Participants’ 
concerns ranged from the inability to get insurance to financial issues and loss of time. 
“Insurance is another problem. How are we supposed to get insurance if we can barely work part 
time, let alone full time. Yet we need insurance for our meds.” (P 1506, female, UC) 
Discussion 
In this study, the subjective experiences of a large sample of IBD patients were explored 
to identify dimensions of their HRQoL, and compare these dimensions with those used in the SF-
36 and the IBDQ (i.e., the most commonly used generic and disease-specific measures of 
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HRQoL for IBD). The participants revealed six dimensions (and sub-dimensions) that had been 
affected by IBD. In particular, the physical, emotional, and social dimensions illuminated here 
were included in the HRQoL measures we examined. However, the cognitive, practical, and self-
regulation dimensions revealed were not referred to in either measure, and warrant further 
thought and discussion. A comparison of the current findings to the SF-36 and the IBDQ is 
provided in Table 2.  
The first new finding, related to the cognitive dimension of HRQoL, has not been 
discussed routinely in the IBD literature. Given that cognitive functioning has been examined in 
relation to cancer [23], stroke [24], multiple sclerosis [25], and rheumatoid arthritis [26] (i.e., 
other chronic disease populations), this is a dimension that should be considered relevant for IBD 
patients. While Loonen and colleagues [27] have suggested that a decrease in cognitive 
functioning can be an issue for IBD patients, our findings also point to a possible re-
conceptualization of the dimension to include excessive attending to the disease. Unfortunately, 
neither the SF-36 nor the IBDQ examine this dimension in any relevant way. Taken together, 
these findings emphasize that further research is needed to ensure that the cognitive dimension is 
acknowledged by researchers and clinicians, and to eventually see that it is included in measures 
of HRQoL. 
Based on the necessity to confront IBD on a daily basis, we were not surprised by our 
second unique finding that the disease exerted a strain on the participants’ finances, time, and 
other resources. The practical dimension of HRQoL has been consistently addressed in the 
literature (see Moody et al. [6]), which brings into question why it is not referred to by either the 
SF-36 or the IBDQ. For this particular sample of IBD patients, fewer respondents mentioned this 
dimension than the other five. However, the consequences of changes to this dimension as a 
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result of IBD were often severe and perceived as causing stress in other areas of their lives. As 
with our first finding, further research will also be needed to ensure that this is a dimension that 
necessitates inclusion in HRQoL measures for IBD patients.  
Although control has been identified previously as a concern for IBD patients [3], our 
third finding regarding the self-regulation dimension is  also an area that is not assessed by the 
SF-36 or the IBDQ. For the purposes of this analysis, we conceptualized self-regulation along a 
continuum of control. Perceptions of control are well-known to enhance adjustment to chronic 
illness, and have been shown to be particularly beneficial when symptom or disease severity is 
high [28, 29]. In this context control perceptions may serve as a coping resource that can 
moderate the impact of symptom severity on adjustment [28].  
Research has indicated that the perception of control and feelings of self-efficacy can also 
be extremely adaptive for IBD patients [1], making it an important aspect of HRQoL. However, 
there has been less emphasis placed on what the patients express about their own self-regulation 
in response to the disease threatening their perceptions of control. In this study, there was a clear 
differentiation between those who actively worked to gain control back in their lives, and those 
who had given up their control to the disease. The third group, those who appeared to neither 
give up control nor take control, clearly responded to their disease by meeting challenges, yet 
they seemed to view these responses or changes as being imposed on them by the disease. This 
intermediate category is consistent with other qualitative research which found that patients with 
IBD constantly battle to gain a sense of control over their disease but often feel worn down by 
their attempts [1]. Thus, patients’ whose responses reflected neither taking nor relinquishing 
control may have been struggling to gain control but perceived themselves as less than 
successful. Although subtle, a separate preliminary analysis of the differences in the way patients 
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express IBD-related control suggests that they may indeed reflect discrete categories of control 
that are important for understanding HRQoL [30]. Nonetheless, a more complete investigation of 
patient self-regulation as it relates to HRQoL in people with IBD is warranted.  
The differences between these three groups were subtle and were, again, identified 
through the patients’ use of language. Often a limitation of quantitative survey use is that all 
constructs are pre-defined by the researcher; the rich and contextual differences between 
participants’ narratives are practically indiscernible. Previous qualitative research has 
demonstrated the need for the inclusion of rich narrative data. In particular, Casati and colleagues 
[3] found that IBD patient concerns were multifaceted and psychosocial in nature, while Hall and 
colleagues [1] identified that IBD patients face extreme social burdens which force them to 
confront their health-related normality on a daily basis. Similarly, we identified multiple 
dimensions of HRQoL through patients’ narratives that would not have been obvious without 
these methods. Recently it has also been suggested that an excellent way to bridge the realities 
and ideals of qualitative (i.e. rich data from a smaller sample) and quantitative (i.e. large samples 
and objective rigor) methodologies is to use text analysis to analyze open-ended narratives 
quickly [31]. Our study, employing a qualitative method but a large sample size, offers 
preliminary support for this specific type of analysis. The combined contributions of previous 
qualitative research and our own findings suggest that researchers should continue to use 
qualitative methodologies when trying to understand and accurately measure HRQoL. 
In addition to our findings regarding the specific dimensions of HRQoL identified by the 
participants, a secondary issue to consider is how the patients framed the changes in their lives.  
While changes in HRQoL for IBD patients are often referred to in the literature as ‘problems,’ 
there were several cases of participants reporting positive changes in their lives as a result of 
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IBD. In particular, these participants described better eating and exercise habits, and also 
discussed how they became more organized in the process of coping with the disease. While it 
was not our explicit intent to identify positive or negative changes in the patients’ lives, these 
findings are consistent with the positive psychology movement and the greater acknowledgement 
of the positive experiences of patients with chronic disease [32, 33]. Indeed, researchers  have 
suggested that IBD patients can and do experience a HRQoL similar to ‘healthy’ individuals 
[34], and our study also supports the notion that not all people will frame their disease from a 
negative point of view. This has implications not only for how we research HRQoL, but how we 
measure it as well. Researchers, many of whom may not have IBD themselves, may unwittingly 
marginalize the very population they are studying by not keeping their assumptions about the 
disease in check, and using terminology that may not reflect the participants’ experiences. This is 
certainly an issue to be considered for future work with IBD populations. 
One limitation of this study involves researcher bias, which is present in all forms of 
research but only acknowledged within certain epistemological standards. As with all qualitative 
research, there is a degree of subjectivity to this analysis which must be acknowledged. 
However, in qualitative research, trustworthiness is the equivalent of reliability and validity in 
quantitative work. For this study, trustworthiness was assured in two ways: two researchers 
reviewed and discussed the themes as a means of data triangulation and peer review, and all 
emergent themes were eventually referenced against relevant literature.  
A second issue involves the method in which the qualitative responses were collected.  
Participants were only asked one open-ended question about their experiences with IBD via an 
electronic survey. Although the question was asked after completion of the IBDQ, this measure 
did not appear to affect participant responses, and rather, many unique dimensions of HRQoL 
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were discussed. Further, a traditional interview may have allowed for additional probing or 
reflective questions. However, survey methods for obtaining qualitative data have the advantage 
of eliminating the problems of response effects known to occur in face to face or phone 
interviews [39]. Moreover, there is mounting evidence that the qualitative responses obtained 
through electronic surveys may be superior to those obtained through traditional paper surveys 
completed by mail, with several studies finding that respondents write comments that are 
lengthier and more self-disclosing in electronic surveys than those written in mail surveys [40-
43]. In addition to the large volume of responses that using this sampling method permitted, we 
believe that using an electronic survey provided an appropriate and valid way to gather 
qualitative responses to address our research question.   
Other possible limitations to be considered when interpreting our findings include the 
characteristics of the sample. Respondents were predominantly Caucasian and female with CD. 
Research has indicated that of the three types of IBD, UC is most prevalent, but that in the long 
term, incidence rates for UC and CD generally match [35]. At least two studies also suggest that 
IBD patient samples recruited from the Internet tend to have a poorer overall HRQoL than those 
recruited from clinics [36,37]. Therefore it is possible that, the positive changes in HRQoL we 
found notwithstanding, our sample may have been worse off with respect to HRQoL than a 
comparable clinic-based sample. However, given the purpose of our study, to examine the 
dimensions of HRQoL affected by living with IBD from the patients’ perspective, addressing 
this issue with a sample of IBD patients with poorer quality of life may be preferable, and even 
desirable.  For example, in one qualitative investigation of IBD patients’ lived experiences, only 
patients with the lowest scores on the IBDQ were included in the qualitative analysis as it was 
reasoned that such individuals would provide the richest range of experiences [1]. It must be 
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acknowledged that participants with potentially poorer HRQoL may not have discussed as many 
positive changes in their lives as another group of IBD patients. Although our sample 
characteristics may not be fully representative of the larger IBD population, we generally concur 
with Vanderheyden and colleagues [38] that the intent of qualitative research is to extend, not 
test theories. From this perspective the generalizability of our findings, which remain to be 
verified, is less important than the extensions to existing models of HRQoL that we have 
proposed.  
The results of this study indicate that when participants are asked how IBD has affected 
their lives, they will largely discuss issues that are already identified in the literature and 
integrated within measures of HRQoL. Because the point of such measures is to collect data 
about patients’ experiences, this suggests that we, as researchers and practitioners, are on the 
right track when it comes to understanding how IBD affects a patient’s HRQoL. However, our 
findings have revealed that it is critical to continue examining how the patients themselves live 
and frame their experiences with IBD. In the process, we can only improve our ability to 
measure patient HRQoL, and effectively respond through appropriate treatment and intervention. 
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Table 1. Demographic characteristics of the three samples
   Group 
  Total IBD Sample Included in 
Final Analysis
Not included in 
Final Analysis 
N 291 282 9 
Sex (%)    
 Female 75.3% 75.2% 77.8% 
 Male 23.7% 23.8% 22.2% 
Age    
 Mean 36.2 36.3 33.0 
SD 11.92 11.85 14.29 
 Range (13-77) (13-77) (14-55) 
Ethnicity (%)    
 Caucasian 96.0% 100% 95.8% 
 Asian 2.9% 0 3.0% 
 Hispanic .7% 0 .8% 
 Aboriginal .4% 0 .4% 
Country of Residence (%)    
 Canada 23.7% 23.4% 33.3% 
 USA 60.5% 61.7% 22.2% 
 United Kingdom 8.2% 8.2% 11.1% 
 Australia/New Zealand 3.7% 3.6% 11.1% 
 Europe 3.3% 2.9% 22.2% 
 Other .3% .4% 0 
Level of Education (%)    
 High School 17.5% 17.5% 12.5% 
 University 57.4% 57.4% 62.5% 
 Graduate 25.1% 25.1% 25% 
Employment Status (%)    
 Full time 50.9% 50.4% 66.7% 
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 Part time 18.2% 18.8% 0 
 Unemployed/Retired 21.4% 21.1% 33.3% 
 Disabled 9.5% 9.8% 0 
Relationship Status (%)    
 Married/Living with 58.7% 60.3% 11.1% 
 Divorced/Separated 10.8% 10.1% 33.3% 
 Never Married 29.7% 28.9% 55.6% 
 Widowed .7% .7% 0 
Type of IBD (%)    
 CD 65.2% 66.2% 33.3% 
 UC 27.9% 26.6% 66.7% 
 Other IBD 7.0% 7.2% 0 
Years Since Diagnosed    
 Mean 9.6 9.7 6.3 
SD 8.743 8.746 8.733 
 Range (0-49) (0-49) (1-24) 
SD = standard deviations 
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Table 2. Comparison of current HRQoL dimensions with the SF-36 and IBDQ 
SF-36 IBDQ Current Findings 
Physical Functioning 
Role Physical 
Bodily Pain 
General Health 
Vitality 
Bowel Symptoms 
Systemic Symptoms
Physical: 
      Systemic Functioning 
      Daily Functioning 
      Energy/Vitality 
      Pain 
Social Functioning Social Social 
Role Emotional  Emotional Emotional 
Mental Health  Cognitive: 
      Functioning 
      Attending to Disease 
  Self-Regulation: 
      Taking Control 
      Loss of Control 
      Neutral 
  Practical 
